Printer Friendly
The Free Library
14,550,685 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Montgomery & Co. LLC Announces Investment Opinion: Initiates Coverage on Gilead Sciences Inc. (GILD).


SAN FRANCISCO -- Montgomery & Co., LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
, a leading investment bank for growth companies in the information technology, communications, healthcare and media sectors, announced today that Research Analyst Shiv shiv  
n. Slang
A knife, razor, or other sharp or pointed implement, especially one used as a weapon.



[Probably Romany chiv, blade.]

Noun 1.
 Kapoor has initiated coverage on Gilead Sciences Inc. (GILD -- $50.69). Gilead is a biotech company focused on infectious diseases. It sells five drugs, Truvada, Viread and Emtriva, for HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  treatment; AmBisome, for fungal infections; and Hepsera for chronic hepatitis B infection. Gilead receives royalties on three other drugs, Tamiflu, for flu; Vistide, for CMV retinitis retinitis /ret·i·ni·tis/ (ret?i-ni´tis) inflammation of the retina.

retinitis circina´ta , circinate retinitis circinate retinopathy.
; and Macugen for age-related macular degeneration Age-related macular degeneration (ARMD)
Degeneration of the macula (the central part of the retina where the rods and cones are most dense) that leads to loss of central vision in people over 60.
.

About Montgomery & Co., LLC

Founded in 1986 to provide strategic capital-formation advisory services to leading aerospace, defense and related technology companies, today, Montgomery & Co. provides research, sales & trading coverage, strategic advisory and M&A services, and public and private financings to growth companies in the information technology, communications, healthcare and media & entertainment businesses.

As part of the Equity Capital Markets Group, the research analysts' mandate is to find undercovered growth companies in technology and healthcare to provide value-added services to the Firm's clients.

Based in Santa Monica, CA, Montgomery & Co. also has offices in San Diego, San Francisco, Kirkland, WA and Orlando, FL. Montgomery & Co. is a member of the National Association of Security Dealers, Inc. (NASD NASD

See: National Association of Securities Dealers


NASD

See National Association of Securities Dealers (NASD).
), and its professional associates are registered with the NASD-SIPC. For more information, please visit, www.monty.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 1, 2005
Words:223
Previous Article:IDC Predicts That Moderate Spending Growth Will Push IT Vendors Toward Disruptive Business Models.(Company Profile)
Next Article:AMD Dual-Core Laptop Offered First by WidowPC; New 'Sting 917X2' Laptop Rivals Desktops in Performance.
Topics:



Related Articles
GILEAD SUBMITS MAA TO EMEA FOR ADEFOVIR DIPIVOXIL 10 MG.
Remodeling completed at 276 Fifth Avenue.(Brief Article)
Stock Market Ratings by StockPickReport.com for Wal-Mart Stores, Applied Digital Solution, Halliburton, PepsiCo, Gilead Sciences.
Gilead Sciences to Present at Two Upcoming Investor Conferences.
Gilead Sciences to Present at Two Upcoming Investor Conferences.
Gilead Sciences to Present at Two Upcoming Investor Conferences.
Gilead Sciences Conference Call - Research and Markets offers a brief of 'Gilead Sciences' Conference Call.
Gilead Sciences to Present at Two Upcoming Investor Conferences.
Gilead Announces Dismissal of Securities Litigation.
Gilead Sciences to Present at Two Upcoming Investor Conferences.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles